Home > Healthcare > Medical Devices > Therapeutic Devices > Nephrostomy Devices Market

Nephrostomy Devices Market Trends

Report ID: GMI4325
Published Date: May 2023
Report Format: PDF

Download Free Sample

Nephrostomy Devices Market Trends

Increasing prevalence of kidney disorders is expected to augment the demand of nephrostomy devices across the globe. Factors such as changes in diet and lifestyle, increased prevalence of obesity, and ageing population will fuel the market growth. Kidney disorders such as kidney stones, tumors, and infections can cause urinary tract obstructions that requires nephrostomy devices to drain urine from the kidney. For instance, according to the U.S. Department of Health and Human Services and National Cancer Institute, in 2023 report, estimated to witness around 82,290 new cases of bladder cancer in the U.S. These rising incidence rate of chronic ailments is expected to increase the product adoption rate in several countries globally. Therefore, the afore-mentioned statistics are expected to drive the adoption of nephrostomy devices.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for nephrostomy devices was worth around USD 1.1 billion in 2022 and is projected to surpass the valuation of around USD 2.4 billion by 2032 attributed to the high prevalence of kidney disorders, coupled with rising demand for minimally invasive surgeries.

The guidewires segment held over 32% revenue share and dominated the nephrostomy devices industry in 2022. Several benefits offered by guidewires in the management of kidney disorders are fueling product usage.

U.S. market for nephrostomy devices is projected to amass around USD 863 million by the end of 2032 driven by the presence of key market players and an increase in the number of chronic diseases.

Angiodynamics, Argon Medical Devices Inc, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Medical, Envaste Ltd., Meditech, Devices Pvt. Ltd., Olympus Corporation, ROCAMED, Teleflex, Inc., and Uresil LLC., among others.